Table 4.
Therapeutic efficacy of NSAID therapy versus exercise therapy during 3 months
| Parameter | NSAID group | Exercise group | Significance |
| VAS | －44.0 ± 15.3 | －35.8 ± 8.07 | N.S (p = 0.6138) |
| RDQ | －5.00 ± 2.78 | －3.20 ± 1.03 | N.S (p = 0.4750) |
| SF-36 (eight scaled scores) | |||
| 1) physical functioning | 1.01 ± 4.86 | 6.43 ± 3.09 | N.S (p = 0.3364) |
| 2) role physical | 16.3 ± 6.16 | 16.0 ± 4.63 | N.S (p = 0.4135) |
| 3) bodily pain | 4.27 ± 4.07 | 7.45 ± 3.05 | N.S (p = 0.5377) |
| 4) general health | 1.83 ± 4.67 | 3.77 ± 2.93 | N.S (p = 0.7147) |
| 5) vitality | 0.87 ± 3.54 | 5.39 ± 2.64 | N.S (p = 0.3168) |
| 6) social functioning | 3.24 ± 4.07 | 4.40 ± 2.60 | N.S (p = 0.8043) |
| 7) role emotional | 2.46 ± 8.50 | 7.98 ± 3.94 | N.S (p = 0.5105) |
| 8) mental health | 2.29 ± 4.32 | 5.77 ± 2.77 | N.S (p = 0.4864) |
Data are the mean ± standard error or the number unless otherwise indicated.
N.S: Not significant
VAS: Visual analog scale
RDQ: Roland Morris Disability Questionnaire score
S.D: Significant difference
SF-36: 36-Item Short-Form Health Survey